Actively Recruiting

Phase 1
Age: 18Years +
All Genders
NCT07312903

DPTX3186 in Wnt Pathway Activated Solid Tumors

Led by Dewpoint Therapeutics · Updated on 2026-01-12

40

Participants Needed

2

Research Sites

130 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a first-in human clinical study of DPTX3186 in subjects with Wnt-pathway activated solid tumors where no other treatments exist. The study will evaluate safety, pharmacokinetics, and initial activity of DPTX3186, as well as explore pharmacodynamic parameters to identify potential biomarkers of efficacy

CONDITIONS

Official Title

DPTX3186 in Wnt Pathway Activated Solid Tumors

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Histologically or cytologically confirmed solid tumor known to activate the Wnt pathway (e.g., colorectal cancer, gastric cancer, lung cancer, triple negative breast cancer) with no approved treatment options
  • At least one measurable target lesion as defined by RECIST v1.1 on CT, PET/CT, or MRI
  • ECOG performance status of 0 or 1
  • Physiological conditions allowing oral medication absorption (no colostomy or ileostomy)
  • Age 18 years or older (or age of majority per local regulation)
  • Life expectancy of at least 3 months
  • Willing and able to comply with study protocol requirements
Not Eligible

You will not qualify if you...

  • Symptomatic or uncontrolled brain metastasis requiring concurrent treatment
  • Another malignancy progressing or requiring active treatment within last 2 years (except basal cell carcinoma, in situ cervical cancer, etc.)
  • Inadequate organ function
  • Known hypersensitivity to study drug or its ingredients

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

NEXT San Antonio

San Antonio, Texas, United States, 78229

Actively Recruiting

2

NEXT Virginia

Fairfax, Virginia, United States, 22031

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SEQUENTIAL

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here